Aditi Ramakrishnan, MD, MSc, explains how pharmacy benefit gaps and prior authorization denials keep patients from long-acting injectable PrEP.
Aditi Ramakrishnan, MD, Msc
Advertisement
Aditi Ramakrishnan, MD, MSc, is an assistant professor in the Division of Infectious Diseases at Washington University in St. Louis School of Medicine.
Articles by Aditi Ramakrishnan, MD, Msc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Real-World AMKD Data Highlight Quick Progression, Unmet Needs
3
Insurance Barriers Tied to Missed Long-Acting PrEP Starts
4
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
5